Results 161 to 170 of about 49,818 (236)

PanERBB CAR T-cells: Shifting gears toward a cure for fanconi anemia head/neck cancers. [PDF]

Mol Ther Oncol
Wiek C, Hüsken S, Scheckenbach K, Eikelberg I, Niktoreh N, Hanenberg H.   +5 more
europepmc   +1 more source

Exploring the mechanism of action of Kaixin San in treating dementia based on network pharmacology and molecular docking. [PDF]

Medicine (Baltimore)
Liu S, Zhang Z.
europepmc   +1 more source

Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in <i>Tpl2</i>^-^/- Mice. [PDF]

Cancers (Basel)
Purkey LR, Mehedincu S, Irvine C, Akdag R, Little M, Kothmann WW, Rus K, Greenberg E, Shady N, DeCicco-Skinner K.   +9 more
europepmc   +1 more source

Single-cell profiling of ERBB family receptors identifies ERBB3 as a key regulator in head and neck squamous cell carcinoma progression. [PDF]

Discov Oncol
Luo Y, Li Y, Liu S, Hu R, Wu J.
europepmc   +1 more source

Amphiregulin and Epiregulin Confer Radioresistance in Esophageal Squamous Cell Carcinoma Through Oxidative Phosphorylation. [PDF]

Adv Sci (Weinh)
Lin Z, Yao M, Xu X, Zhang D, Xu L, Rong L, Wang X, Duan Y, Chen C, Gu J, Zhang Y, Liu Q, Ye Q, Cui G, Hao Y, Ma X.   +15 more
europepmc   +1 more source

Pan-cancer multi-omic ERBB2-HER2 characterization using next-generation sequencing and quantitative proteomics. [PDF]

NPJ Precis Oncol
Hunt AL, Randall J, Ogata JD, Johnston L, Swain W, Melvin S, Sharma M, Calvert V, Maxwell GL, Bateman NW, Petricoin EF, Conrads TP, Cannon TL.   +12 more
europepmc   +1 more source

Functional properties of skeletal myotube-derived extracellular vesicles based on microRNA profiles: a comparative analysis with mesenchymal stem cell-derived extracellular vesicles. [PDF]

Sci Rep
Kawamoto Y, Yamaguchi A, Ma X, Fu Y, Guo Q, Uemura M, Fujino H, Maeshige N.   +7 more
europepmc   +1 more source

Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvals. [PDF]

Contemp Clin Trials Commun
Kasim A, Anastasiou M, Loizou E, Dimakakos A, Georganaki M, Mourelatos I, Karelis P, Esposito M, Zhou H, Chen TT, Skaltsas D, Stockman P.   +11 more
europepmc   +1 more source

The future of urothelial carcinoma: a 2024-2025 update of early-phase trials of novel therapeutic agents. [PDF]

Curr Opin Urol
Lee YHA, Wong CM, Liu AQ, Teoh JY.
europepmc   +1 more source

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes. [PDF]

FEBS J
Vaparanta K, Song Z, Farahani I, Jokilammi A, Merilahti J, Örling J, Virtanen N, Haapaniemi P, Sahlgren C, Elenius K, Paatero I.   +10 more
europepmc   +1 more source